“There’s a little over 1,200 clinical trials worldwide, and about half of those are in the US. Over 100 of those are in phase III, so we’re getting really close to getting more approved.”

Can the skills shortage in the world of cell and gene therapy be overcome? Sarah Stoll (Director, Project Farma) joins industry experts in providing insights into the current state of the cell and gene therapy industry and solutions for the manufacturing talent shortfall in “Mind the Skills Gap”.

CLICK HERE to read the full article.